<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Palopegteriparatide</title><link>https://peptidescanner.com/peptides/palopegteriparatide/</link><description>Versioned, source-linked PeptideScanner evidence objects for Palopegteriparatide. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/palopegteriparatide.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT07081997</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07081997-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07081997-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#clinicaltrials-gov-nct07081997-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-11-05. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07264634</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07264634-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07264634-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#clinicaltrials-gov-nct07264634-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-08-07. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07345494</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07345494-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07345494-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#clinicaltrials-gov-nct07345494-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-03-02. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07706764</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07706764-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07706764-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#clinicaltrials-gov-nct07706764-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-28. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA216490</title><link>https://peptidescanner.com/stories/fda-drugs-nda216490/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda216490:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#fda-drugs-nda216490-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2024-08-09. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2025-16269</title><link>https://peptidescanner.com/stories/federal-register-2025-16269/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2025-16269:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#federal-register-2025-16269-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2025-08-26. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2026-10277</title><link>https://peptidescanner.com/stories/federal-register-2026-10277/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2026-10277:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#federal-register-2026-10277-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2026-05-22. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Palopegteriparatide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39437769-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39437769-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-39437769-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-01-06. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Value Contribution of Palopegteriparatide in Adult Patients with Chronic Hypoparathyroidism using Multicriteria Decision Analysis (MCDA).</title><link>https://peptidescanner.com/stories/pubmed-pmid-41134515-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41134515-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-41134515-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-11-17. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 years of the phase 2 PaTH forward trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41636590-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41636590-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-41636590-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Palopegteriparatide therapy for hypoparathyroidism: targeting the PTH receptor rouses the sleeping skeleton.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42139093-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42139093-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42139093-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-09-27. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pharmacodynamics of sustained levels of PTH following palopegteriparatide treatment in adults with hypoparathyroidism.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42440695-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42440695-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42440695-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Palopegteriparatide treatment for hypoparathyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case series and literature update.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42614145-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42614145-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42614145-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Off-label palopegteriparatide for severe pediatric postsurgical hypocalcemia.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42789535-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42789535-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42789535-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-07. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Discontinuation of palopegteriparatide in chronic hypoparathyroidism without rebound hypocalcemia.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42871663-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42871663-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42871663-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Palopegteriparatide: Parathyroid Hormone Analog for the Treatment of Chronic Hypoparathyroidism in Adults.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42924498-palopegteriparatide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42924498-palopegteriparatide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42924498-palopegteriparatide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-24. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
